Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues
Cardiomyocytes derived from human induced pluripotent stem cells could be used to generate cardiac tissues for regenerative purposes. Here the authors describe a method to obtain large bioengineered heart tissues showing advanced maturation, functional features and engraftment capacity.
Saved in:
Main Authors: | Ilya Y. Shadrin, Brian W. Allen, Ying Qian, Christopher P. Jackman, Aaron L. Carlson, Mark E. Juhas, Nenad Bursac |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/cf30a3c33e6d47d2acb195744c55d771 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Engineering human pluripotent stem cells into a functional skeletal muscle tissue
by: Lingjun Rao, et al.
Published: (2018) -
Engineering prokaryotic channels for control of mammalian tissue excitability
by: Hung X. Nguyen, et al.
Published: (2016) -
Disrupted neuronal maturation in Angelman syndrome-derived induced pluripotent stem cells
by: James J. Fink, et al.
Published: (2017) -
Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells
by: Shunsuke Funakoshi, et al.
Published: (2021) -
BMI1 enables interspecies chimerism with human pluripotent stem cells
by: Ke Huang, et al.
Published: (2018)